Home/Filings/4/0001628280-22-006733
4//SEC Filing

Koenig Sheldon L. 4

Accession 0001628280-22-006733

CIK 0001434868other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:29 PM ET

Size

4.8 KB

Accession

0001628280-22-006733

Insider Transaction Report

Form 4
Period: 2022-03-17
Koenig Sheldon L.
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2022-03-17$4.58/sh571$2,615194,717 total
Footnotes (1)
  • [F1]Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units.

Issuer

Esperion Therapeutics, Inc.

CIK 0001434868

Entity typeother

Related Parties

1
  • filerCIK 0001766524

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:29 PM ET
Size
4.8 KB